Home Urinary myo-inositol levels in Japanese schoolchildren with normal glucose tolerance
Article
Licensed
Unlicensed Requires Authentication

Urinary myo-inositol levels in Japanese schoolchildren with normal glucose tolerance

  • Eiichiro Satake EMAIL logo , Rie Matsushita , Kazuteru Kitsuda , Kohnosuke Ohtaka , Eiko Nagata , Rie Yamaguchi , Shinichiro Sano , Yasuko Fujisawa , Toshiki Nakanishi , Yuichi Nakagawa and Takehiko Ohzeki
Published/Copyright: September 11, 2015

Abstract

Background: Urinary myo-inositol (UMI) level is elevated in adult diabetic patients, and also increases after glucose loading. However, the relationship between UMI and plasma glucose levels in children is unknown. We aimed to assess whether UMI is a practical marker for glucose intolerance in children or not.

Methods: In Study 1 (328 schoolchildren), fasting and postprandial UMI were measured, with ΔUMI defined as the difference between fasting and postprandial UMI levels. In Study 2, oral glucose tolerance tests and UMI measurements were conducted in 18 children with suspected having diabetes.

Results: For Study 1, ΔUMI was observed [−0.65 (−3.9, 1.35) mg/g creatinine]. For Study 2, children with diabetes or impaired glucose tolerance had a significantly higher ΔUMI than children with normal glucose tolerance.

Conclusions: These studies demonstrated the normal range of UMI in children and possibility of a novel biomarker for early detection of glucose intolerance in children.


Corresponding author: Eiichiro Satake, MD, PhD, Genetics and Epidemiology, Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215, USA, Phone: +1-617-309-4586, Fax: +1-617-309-2667, E-mail: ; Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan; Research Division, Joslin Diabetes Center, Boston, MA, USA; and Department of Medicine, Harvard Medical School, Boston, MA, USA

Acknowledgments

We thank Prof. Tsutomu Ogata for his valuable and constructive suggestions. We also thank Drs. Michiko Myokai, Tsutomu Kamimaki, Yoshifumi Miyagi, Akira Kubota, Osamu Natsume, and Akira Endo for collecting the data and checking the questionnaires. This study was unfunded.

Conflicts of interest: The authors declare no conflicts of interest relevant to this article.

References

1. Schimpf K, Thompson L, Baugh S. Determination of myo-inositol (free and bound as phosphatidylinositol) in infant formula and adult nutritionals by liquid chromatography/pulsed amperometry with column switching: first action 2011.18. J AOAC Int 2012;95:937−42.10.5740/jaoacint.CS2011_18Search in Google Scholar

2. Clements RS Jr, Darnell B. Myo-inositol content of common foods: development of a high-myo-inositol diet. Am J Clin Nutr 1980;33:1954−67.10.1093/ajcn/33.9.1954Search in Google Scholar

3. Goodhart RS. Bioflavonoids. Modern nutrition in health and disease. Philadelphia: Lea & Febiger, 1973:259−67.Search in Google Scholar

4. Eisenberg Jr F, Bolden AH. Biosynthesis of inositol in rat testis homogenate. Biochem Biophys Res Commun 1963;12:72−7.10.1016/0006-291X(63)90416-9Search in Google Scholar

5. Hauser G, Finelli VN. The biosynthesis of free and phosphatide myo-inositol from glucose by mammalian tissue slices. J Biol Chem 1963;238:3224−8.10.1016/S0021-9258(18)48650-4Search in Google Scholar

6. Clements RS Jr, Reynertson R. Myoinositol metabolism in diabetes mellitus. Effect of insulin treatment. Diabetes 1977;26:215−21.10.2337/diabetes.26.3.215Search in Google Scholar

7. Hammerman MR, Sacktor B, Daughaday WH. Myo-inositol transport in renal brush border vesicles and it inhibition by d-glucose. Am J Physiol 1980;239:F113−20.10.1152/ajprenal.1980.239.2.F113Search in Google Scholar PubMed

8. Olgemoller B, Schwaabe S, Schleicher ED, Gerbitz KD. Upregulation of myo-inositol transport compensates for competitive inhibition by glucose. An explanation for the inositol paradox? Diabetes 1993;42:1119−25.10.2337/diabetes.42.8.1119Search in Google Scholar

9. Gabbay KH. Hyperglycemia, polyol metabolism, and complications of diabetes mellitus. Annu Rev Med 1975;26:521−36.10.1146/annurev.me.26.020175.002513Search in Google Scholar PubMed

10. Kawa JM, Przybylski R, Taylor CG. Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db/db mouse and streptozotocin diabetic rat. Exp Biol Med (Maywood) 2003;228:907−14.10.1177/153537020322800806Search in Google Scholar PubMed

11. Daughaday WH, Larner J. The renal excretion of inositol in normal and diabetic human beings. J Clin Invest 1954;33:326−32.10.1172/JCI102901Search in Google Scholar PubMed PubMed Central

12. Kennington AS, Hill CR, Craig J, Bogardus C, Raz I, et al. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med 1990;323:373−8.10.1056/NEJM199008093230603Search in Google Scholar

13. Ostlund RE Jr, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, et al. D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci USA 1993;90:9988−92.10.1073/pnas.90.21.9988Search in Google Scholar

14. Clements RS Jr, DeJesus PV Jr, Wineqrad AI. Raised plasma-myoinositol levels in uraemia and experimental neuropathy. Lancet 1973;1:1137−41.10.1016/S0140-6736(73)91143-4Search in Google Scholar

15. Sarashina G, Yamakoshi M, Noritake M, Takahashi M, Kure M, et al. A study of urinary myo-inositol as a sensitive marker of glucose intolerance. Clin Chim Acta 2004;344:181−8.10.1016/j.cccn.2004.02.026Search in Google Scholar

16. Ikezaki H, Furusyo N, Okada K, Ihara T, Hayashi T, et al. The utility of urinary myo-inositol as a marker of glucose intolerance. Diabetes Res Clin Pract 2014;103:88−96.10.1016/j.diabres.2013.11.018Search in Google Scholar

17. Kawazu S, Yamagata F. [Detection of glucose intolerance by urinary myo-inositol]. Nihon Rinsho 2005;63:400−5.Search in Google Scholar

18. Yamakoshi M, Takahashi M, Kouzuma T, Imamura S, Tsuboi I, et al. Determination of urinary myo-inositol concentration by an improved enzymatic cycling method using myo-inositol dehydrogenase from flavobacterium sp. Clin Chim Acta 2003;328:163−71.10.1016/S0009-8981(02)00426-6Search in Google Scholar

19. Yamakoshi M, Kawazu S. Lucica mi urinary myoinositol kit: a new diagnostic test for diabetes mellitus and glucose intolerance. Mol Diagn Ther 2008;12:189−91.10.1007/BF03256283Search in Google Scholar

20. Ministry of education, sports, science and technology-Japan. Nutrition standards for school lunch, 2009. Available at: http://mext.go.jp/b_neby/hakusho//nc/__icsFiles/afieldfile/2009/09/10/1283812_l.pdf/.Search in Google Scholar

21. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig 2010;1:212−28.10.1111/j.2040-1124.2010.00074.xSearch in Google Scholar

22. Geistanger A, Arends S, Berding C, Hoshino T, Jeppsson JO, et al. Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c in the United States, Japan, and Sweden. Clin Chem 2008;54:1379−85.10.1373/clinchem.2008.103556Search in Google Scholar

23. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539−53.10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-SSearch in Google Scholar

24. Skinner AM, Addison GM, Price DA. Changes in the urinary excretion of creatinine, albumin and n-acetyl-beta- d-glucosaminidase with increasing age and maturity in healthy schoolchildren. Eur J Pediatr 1996;155:596−602.10.1007/BF01957912Search in Google Scholar PubMed

25. Invitti C, Guzzaloni G, Gilardini L, Morabito F, Viberti G. Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care 2003;26:118−24.10.2337/diacare.26.1.118Search in Google Scholar PubMed

26. Ek AE, Rossner SM, Hagman E, Marcus C. High prevalence of prediabetes in a Swedish cohort of severely obese children. Pediatr Diabetes 2015;16:117–28.10.1111/pedi.12136Search in Google Scholar PubMed

27. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802−10.10.1056/NEJMoa012578Search in Google Scholar PubMed

28. Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, et al. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity – a problem that is no longer restricted to minority groups. Eur J Endocrinol 2004;151:199−206.10.1530/eje.0.1510199Search in Google Scholar PubMed

29. Yokoyama H, Okudaira M, Otani T, Takaike H, Miura J, et al. Existence of early-onset niddm Japanese demonstrating severe diabetic complications. Diabetes Care 1997;20:844−7.10.2337/diacare.20.5.844Search in Google Scholar PubMed

30. Yokoyama H, Okudaira M, Otani T, Watanabe C, Takaike H, et al. High incidence of diabetic nephropathy in early-onset Japanese niddm patients. Risk analysis. Diabetes Care 1998;21:1080−5.10.2337/diacare.21.7.1080Search in Google Scholar PubMed

Received: 2015-3-4
Accepted: 2015-8-18
Published Online: 2015-9-11
Published in Print: 2016-2-1

©2016 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. REVIEW
  3. Obesity-associated sympathetic overactivity in children and adolescents: the role of catecholamine resistance in lipid metabolism
  4. MINI REVIEW
  5. Idiopathic infantile hypercalcemia: case report and review of the literature
  6. ORIGINAL ARTICLES
  7. Levothyroxine replacement in primary congenital hypothyroidism: the higher the initial dose the higher the rate of overtreatment
  8. Effect of auditory guided imagery on glucose levels and on glycemic control in children with type 1 diabetes mellitus
  9. Kidney injury molecule-1 and neutrophil gelatinase associated lipocalin in normoalbuminuric diabetic children
  10. Use of the triglyceride to HDL cholesterol ratio for assessing insulin sensitivity in overweight and obese children in rural Appalachia
  11. Carotid intima media thickness in obese children: is there an association with hyperlipidemia?
  12. Schoolchildren born VLBW or VLGA show height-related changes in body composition and muscle function but no evidence of metabolic syndrome risk factors. Results from the NEOLONG study
  13. Topical dihydrotestosterone to treat micropenis secondary to partial androgen insensitivity syndrome (PAIS) before, during, and after puberty – a case series
  14. Urinary myo-inositol levels in Japanese schoolchildren with normal glucose tolerance
  15. Barriers in communication and available resources to facilitate conversation about infertility with girls diagnosed with Turner syndrome
  16. Analysis of the PAX8 gene in 32 children with thyroid dysgenesis and functional characterization of a promoter variant
  17. Decrease of small dense LDL and lipoprotein-associated phospholipase A2 due to human growth hormone treatment in short children with growth hormone deficiency and small for gestational age status
  18. Rare and curable renin-mediated hypertension: a series of six cases and a literature review
  19. CASE REPORTS
  20. Vulvar fetal rhabdomyoma mimicking 46XX sex differentiation disorder
  21. Simultaneous occurrence of diabetic ketoacidosis, thyroid storm, and multiple cerebral infarctions due to Moyamoya disease
  22. Brown-Vialetto-Van Laere syndrome: two siblings with a new mutation and dramatic therapeutic effect of high-dose riboflavin
  23. Lipomatous nevus and urethral caruncle mistaken for ambiguous genitalia in a female infant
  24. Thyrotropin-secreting pituitary adenoma in an 11-year-old boy with type 1 autoimmune polyglandular syndrome
  25. Changes in facial appearance from neonate to adult in 3-M syndrome patient with novel CUL7 gene mutations
Downloaded on 24.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2015-0107/html
Scroll to top button